Clinical trial
Clinical Assessment of Semaglutide-Induced Weight Reduction in Obese Populations
NCT06825793 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Assessment of Semaglutide-Induced Weight Reduction in Obese Populations
- Lead sponsor
- Beijing Chao Yang Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 20, 2025
- Completion date
- December 31, 2027
- Enrollment
- 56 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.